The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Oct 2017 10:52

RNS Number : 0865U
Midatech Pharma PLC
19 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Midatech Pharma Plc

549300GKR2G40H3QFY57

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

 

Legal & General Group Plc (Group)

 

Legal & General Investment Management Limited (LGIM)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

4. Full name of shareholder(s) (if different from 3.)v

Name

 

Legal & General Assurance Society (LGAS)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

5. Date on which the threshold was crossed or reachedvi:

17 October 2017

6. Date on which issuer notified (DD/MM/YYYY):

 

19 October 2017

 

 

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

L&G - 7.56%

-

L&G - 7.56%

61,034,135

 

Resulting situation on the date on which threshold was crossed or reached

LGIM - 16.83%

-

LGIM - 16.83%

61,034,135

 

Position of previous notification (if

applicable)

L&G - 5.07%

-

L&G - 5.07%

Position of previous notification (if

applicable)

LGIM - 10.35%

-

LGIM - 10.35%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP 0.00005 (L&G Group)

4,616,706

-

7.56%

-

ORD GBP 0.00005 (LGIM)

-

10,275,518

-

16.83%

SUBTOTAL 8. A

10,275,518

16.83%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Legal & General Group (Direct/Indirect)

16.83%

16.83%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

 

Legal & General Assurance Society (Direct)

7.56%

7.56%

 

 

Legal & General Group (Direct/Indirect)

16.83%

16.83%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General Assurance (Pensions Management) Limited

(Direct)

 

0.00%

 

0.00%

Legal & General Group (Direct/Indirect)

16.83%

16.83%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General Investment Management Limited (Indirect)

 

16.83%

 

16.83%

Legal & General Group (Direct/Indirect)

16.83%

16.83%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General (Unit Trust Managers) Limited (Indirect)

9.27%

9.27%

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

 

 

11. Additional informationxvi

 

 

Notification using the total voting rights figure of 10,275,518

 

 

Place of completion

Brunel House, 2 Fitzalan Road, Cardiff, CF24 0EB

Date of completion

19/10/2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMLBLTMBABMBR
Date   Source Headline
14th Aug 20202:05 pmRNSSecond Price Monitoring Extn
14th Aug 20202:00 pmRNSPrice Monitoring Extension
14th Aug 20207:00 amRNSRegistration Statement Declared Effective
10th Aug 20205:36 pmRNSHolding(s) in Company
7th Aug 20207:00 amRNSHolding(s) in Company
6th Aug 20204:54 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
5th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20203:00 pmRNSHolding(s) in Company
31st Jul 20202:48 pmRNSResult of AGM
30th Jul 202011:00 amRNSPrice Monitoring Extension
30th Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20204:35 pmRNSHolding(s) in Company
27th Jul 20209:40 amRNSBroker Option Fully Exercised
27th Jul 20207:00 amRNSUK Placing to Raise £5.0 million
24th Jul 20201:31 pmRNSHolding(s) in Company
24th Jul 20208:43 amRNSForm 8.3 - Midatech Pharma PLC
23rd Jul 20202:41 pmRNSForm 8.3 - Midatech Pharma plc
23rd Jul 20207:00 amRNSCorporate Update & Formal Sale Process Termination
22nd Jul 20203:25 pmRNSForm 8.3 - Midatech Pharma plc
21st Jul 20202:05 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202011:05 amRNSSecond Price Monitoring Extn
21st Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20209:00 amRNSCollaboration for the Q-Sphera platform
3rd Jul 20205:48 pmRNSPosting of Annual Report & Notice of AGM
3rd Jul 20207:00 amBUSForm 8.3 - Midatech Pharma PLC
30th Jun 20201:37 pmRNSPublication of Annual Report
25th Jun 20203:10 pmRNSHolding(s) in Company
25th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
24th Jun 20205:18 pmBUSForm 8.3 - Midatech Pharma plc
24th Jun 202012:01 pmRNSForm 8.3 - Midatech Pharma PLC
18th Jun 20206:25 pmRNSForm 8 (DD) - Midatech Pharma plc
17th Jun 20207:00 amRNSGrant of Options
16th Jun 202010:20 amRNSInvestor Presentation
16th Jun 20207:00 amRNSResults for the year ended 31 December 2019
11th Jun 20203:41 pmRNSForm 8.3 - Midatech Pharma PLC
11th Jun 20203:35 pmRNSForm 8.3 - Midatech Pharma Plc
11th Jun 202010:53 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc (Replacement)
11th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20207:00 amRNSHolding(s) in Company
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202012:57 pmRNSForm 8.3 - Midatech Pharma plc
10th Jun 202011:00 amRNSPrice Monitoring Extension
9th Jun 20205:35 pmRNSForm 8.3 - Midatech Pharma plc
9th Jun 20204:36 pmRNSPrice Monitoring Extension
9th Jun 20204:04 pmRNSPurported Termination of MTX110 Licence Agreement
9th Jun 20202:48 pmEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma PLC
9th Jun 202012:14 pmRNSForm 8.3 - Midatech Pharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.